Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia

Kinase drug discovery represents an active area of therapeutic research, with previous pharmaceutical success improving patient outcomes across a wide variety of human diseases. In pancreatic ductal adenocarcinoma (PDAC), innovative pharmaceutical strategies such as kinase targeting have been unable...

Descripción completa

Detalles Bibliográficos
Autores principales: Creeden, Justin F., Alganem, Khaled, Imami, Ali S., Henkel, Nicholas D., Brunicardi, F. Charles, Liu, Shi-He, Shukla, Rammohan, Tomar, Tushar, Naji, Faris, McCullumsmith, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700673/
https://www.ncbi.nlm.nih.gov/pubmed/33233470
http://dx.doi.org/10.3390/ijms21228823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700673/
https://www.ncbi.nlm.nih.gov/pubmed/33233470
http://dx.doi.org/10.3390/ijms21228823

Ejemplares similares